Voyager Therapeutics (VYGR) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -10.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.67% |
| Dec 31, 2025 | -9.73% |
| Sep 30, 2025 | -9.75% |
| Jun 30, 2025 | -9.96% |
| Mar 31, 2025 | -10.42% |
| Dec 31, 2024 | -13.24% |
| Sep 30, 2024 | -12.88% |
| Jun 30, 2024 | -11.78% |
| Mar 31, 2024 | -10.84% |
| Dec 31, 2023 | -13.44% |
| Sep 30, 2023 | -9.67% |
| Jun 30, 2023 | -5.15% |
| Mar 31, 2023 | -2.67% |
| Dec 31, 2022 | -0.24% |
| Sep 30, 2022 | 5.75% |
| Jun 30, 2022 | 9.58% |
| Mar 31, 2022 | 13.80% |
| Dec 31, 2021 | 19.73% |
| Sep 30, 2021 | 22.44% |
| Jun 30, 2021 | 24.61% |
| Mar 31, 2021 | 28.87% |
| Dec 31, 2020 | 35.24% |
| Sep 30, 2020 | 30.03% |
| Jun 30, 2020 | 23.70% |
| Mar 31, 2020 | 22.41% |
| Dec 31, 2019 | 31.59% |
| Sep 30, 2019 | 53.20% |
| Jun 30, 2019 | 59.04% |
| Mar 31, 2019 | 54.60% |
| Dec 31, 2018 | 58.06% |
| Sep 30, 2018 | 56.36% |
| Dec 31, 2017 | 54.21% |